RLS Global AB (publ) (OM:RLS) announced that RLS Global and ConvaTec Group PLC (LSE:CTEC) have agreed to terminate the collaboration agreement. RLS Global and Convatec have agreed that both parties will work jointly and with the common target to have a smooth handover from Convatec to RLS Global. The RLS Global Board of Directors will consider all strategic options, including a partnership, a sale of the company, a sale of ChloraSolv, or a financial investment in RLS Global.

"The review process will be undertaken with immediate effect, and we have set no timeline for completion of this process", says Lars Johansson, Chairman of the Board, RLS Global. "Bringing ChloraSolv to patients will require resources and capital that RLS Global does not have as of today, and hence we are now initiating a strategic review process," Lars Johansson continues.